TScan Therapeutics
TCRX
#9298
Rank
C$95.32 M
Marketcap
$1.68
Share price
-5.56%
Change (1 day)
-83.13%
Change (1 year)

P/S ratio for TScan Therapeutics (TCRX)

P/S ratio as of April 2025 (TTM): 25.3

According to TScan Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.2959. At the end of 2024 the company had a P/S ratio of 58.0.

P/S ratio history for TScan Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202458.0337.83%
202313.2380.36%
20222.76-74.01%
202110.6